Marathe Supreet P, Jones Matthew I, Ayer Julian, Sun Jessica, Orr Yishay, Verrall Charlotte, Nicholson Ian A, Chard Richard B, Sholler Gary F, Winlaw David S
1 Heart Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia.
2 School of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, Australia.
Asian Cardiovasc Thorac Ann. 2017 Jul;25(6):432-439. doi: 10.1177/0218492317717412. Epub 2017 Jun 13.
Background Successful anatomic repair of congenitally corrected transposition of the great arteries achieves excellent outcomes. Several centers report excellent long-term survival with the Fontan pathway as well. We have selectively applied both approaches depending on individual patient morphology, with anatomic repair preferred but utilizing the Fontan pathway when high technical complexity or operative risk is anticipated. Methods Hospital records over an 18-year period (1998-2016) were reviewed to identify patients with congenitally corrected transposition of the great arteries who underwent surgical management. Physiological repairs and hypoplastic ventricles were excluded. Patient- and procedure-related variables were reviewed. Results We identified 19 patients. Group 1 consisted of 12 anatomic repairs, of which 10 (83.3%) required prior interim staging procedures. Mean age at anatomic repair was 2.6 ± 1.3 years, mean follow-up was 8.7 ± 5.3 years. Nine (75%) patients experienced important complications and 4 (33.3%) required reintervention during follow-up. There were no deaths; one patient required heart transplantation. Group 2 (7 patients) underwent Fontan palliation. Mean age at Fontan completion was 7.2 ± 3.8 years, mean follow-up was 6.3 ± 4 years. There was no reintervention, death, or transplant. Conclusion Patients with congenitally corrected transposition of the great arteries and two adequate-sized ventricles do well with both anatomic repair and the Fontan pathway in the medium term. Excellent outcomes with reduced early complication and reintervention rates can be achieved for this cohort of patients when a strategy of avoiding complex anatomic repair in favor of the Fontan pathway is used.
背景 先天性矫正型大动脉转位的成功解剖修复可取得优异的治疗效果。多个中心报告称,采用Fontan手术路径也能获得出色的长期生存率。我们根据患者个体形态选择性地应用这两种方法,优先选择解剖修复,但在预计技术复杂性高或手术风险大时采用Fontan手术路径。方法 回顾18年期间(1998 - 2016年)的医院记录,以确定接受手术治疗的先天性矫正型大动脉转位患者。排除生理性修复和心室发育不全的患者。对患者和手术相关变量进行回顾。结果 我们确定了19例患者。第1组包括12例解剖修复,其中10例(83.3%)需要先前的临时分期手术。解剖修复时的平均年龄为2.6±1.3岁,平均随访时间为8.7±5.3年。9例(75%)患者出现重要并发症,4例(33.3%)在随访期间需要再次干预。无死亡病例;1例患者需要心脏移植。第2组(7例患者)接受了Fontan姑息手术。Fontan手术完成时的平均年龄为7.2±3.8岁,平均随访时间为6.3±4年。无再次干预、死亡或移植情况。结论 对于先天性矫正型大动脉转位且有两个大小合适心室的患者,解剖修复和Fontan手术路径在中期均效果良好。当采用避免复杂解剖修复而倾向于Fontan手术路径的策略时,该组患者可获得优异的治疗效果,且早期并发症和再次干预率降低。